Advanced Asthma Clinic · Plantation, FL · Dr. Frank Hull, Pulmonologist
South Florida gets over 2,700 hours of sunshine per year -- yet vitamin D deficiency is surprisingly common among asthma patients seen at our Plantation clinic. Multiple clinical studies now link low vitamin D levels to more frequent asthma attacks, greater oral steroid use, and reduced lung function. This does not mean vitamin D deficiency causes asthma, but correcting it in patients who are deficient appears to meaningfully reduce attack frequency.
This guide from Dr. Frank Hull's team at the Advanced Asthma Clinic reviews the clinical evidence, explains how vitamin D influences airway immunity, identifies who is most at risk for deficiency despite living in a sunny climate, and outlines what steps patients can take in consultation with their physician.
Vitamin D is a fat-soluble secosteroid hormone, not just a vitamin. After either skin synthesis (from UVB radiation) or dietary intake, it is converted in the liver to 25-hydroxyvitamin D (25-OH D, the form measured in blood tests), then activated in the kidneys and locally in many tissues -- including lung tissue -- to its active form, 1,25-dihydroxyvitamin D (calcitriol).
The vitamin D receptor (VDR) is expressed on nearly every cell type involved in asthma pathophysiology, including airway epithelial cells, smooth muscle cells, mast cells, eosinophils, T lymphocytes, and macrophages. Through VDR signaling, vitamin D has several relevant effects on airway biology:
Vitamin D suppresses the Th2 immune response that drives allergic asthma -- reducing IL-4, IL-5, and IL-13 production, which in turn lowers eosinophil recruitment and IgE synthesis. At the same time, it promotes the expansion of regulatory T cells (Tregs), which dampen overall airway hyperresponsiveness. In patients with neutrophilic or mixed phenotype asthma, vitamin D also reduces IL-17 and TGF-beta, cytokines involved in steroid resistance and airway remodeling.
Vitamin D upregulates cathelicidin (LL-37) and beta-defensins -- innate antimicrobial peptides that protect the airway epithelium against viral and bacterial invasion. Respiratory viral infections (rhinovirus, influenza, RSV) are the single most common trigger of asthma exacerbations. Observational data consistently show that vitamin D-deficient asthma patients experience more viral-triggered attacks. This antimicrobial mechanism is one reason supplementation trials show a stronger effect on exacerbation reduction than on baseline symptom control.
In vitro studies show that vitamin D reduces airway smooth muscle cell proliferation and attenuates TGF-beta-induced subepithelial fibrosis -- both components of long-term airway remodeling that permanently narrows the airway in severe chronic asthma. Whether supplementation meaningfully reverses established remodeling in clinical practice remains under investigation.
| Study / Meta-analysis | Population | Key Finding | Level of Evidence |
|---|---|---|---|
| Martineau et al. 2017 (Cochrane Review) |
Adults and children; 7 RCTs (n=955) | Vitamin D reduced asthma attacks requiring OCS by 26% (IRR 0.74); benefit strongest in patients with baseline 25-OH D <25 nmol/L | High (systematic review of RCTs) |
| VIDA Trial 2014 (Vitamin D Add-on) |
Adults with symptomatic asthma (n=408) | No significant reduction in first exacerbation in unselected population; post-hoc: benefit in patients with baseline 25-OH D <30 ng/mL | Moderate (RCT, unselected cohort) |
| VAPOS Trial 2022 (Vitamin D in Asthma) |
Adults with persistent asthma and 25-OH D <30 ng/mL | High-dose D3 (100,000 IU loading + 4,000 IU/day) reduced severe exacerbation rate by ~30% vs. placebo at 12 months | Moderate (RCT) |
| Jolliffe et al. 2021 (IPD Meta-analysis) |
Pooled individual patient data; 8 RCTs (n=1,078) | Supplementation reduced rate of asthma attacks requiring OCS by 30% in vitamin D-deficient patients; no effect in those already sufficient | High (individual patient data meta-analysis) |
| Brehm et al. 2012 (Puerto Rican children) |
Children with asthma (n=560) | Each 10 ng/mL increase in 25-OH D associated with 35% lower odds of hospitalization for asthma | Moderate (prospective cohort) |
The consistent signal across this evidence base: vitamin D supplementation benefits asthma patients who are deficient, not those who are already sufficient. Blanket supplementation in patients with normal levels does not appear to improve asthma control.
The paradox of vitamin D deficiency in South Florida is real. Despite abundant UVB radiation, a substantial proportion of asthma patients presenting to our Plantation clinic have insufficient levels. The following risk factors explain why:
| Risk Factor | Mechanism | Prevalence in Asthma Patients |
|---|---|---|
| Indoor lifestyle / air conditioning | No UVB penetrates glass; indoor time eliminates skin synthesis | Very common -- especially office workers and patients with heat-sensitive asthma |
| Consistent high-SPF sunscreen use | SPF 30 reduces cutaneous vitamin D synthesis by ~97% | Common -- particularly among patients who avoid outdoor triggers |
| Darker skin pigmentation | Melanin competes with 7-dehydrocholesterol for UVB photons; requires 3-6x longer exposure for equivalent synthesis | High -- South Florida has large Hispanic and Black populations with increased deficiency risk |
| Obesity (BMI >30) | Vitamin D is fat-soluble; sequestration in adipose tissue reduces circulating 25-OH D | Common -- obesity is also an independent asthma risk factor |
| Older age (>65) | Skin thickness and 7-DHC concentration decline with age, reducing UVB synthesis efficiency | Moderate -- prevalent in Dr. Hull's COPD and severe asthma adult population |
| Malabsorption / GI conditions | Inflammatory bowel disease, celiac disease, bariatric surgery reduce fat-soluble vitamin absorption | Lower prevalence but important to identify |
| Chronic oral corticosteroid use | OCS impairs vitamin D metabolism and increases urinary calcium excretion; long-term use depletes vitamin D stores | Relevant for severe asthma patients on maintenance OCS |
Vitamin D status is measured as serum 25-hydroxyvitamin D (25-OH D). This is the appropriate test -- not 1,25-dihydroxyvitamin D (the active form), which does not accurately reflect body stores.
| 25-OH Vitamin D Level | Classification | Clinical Interpretation for Asthma |
|---|---|---|
| <12 ng/mL (<30 nmol/L) | Deficient | Significantly increased exacerbation risk; supplementation strongly indicated; physician evaluation for secondary causes |
| 12-20 ng/mL (30-50 nmol/L) | Insufficient | Elevated risk; supplementation typically recommended; monitor airway control |
| 20-30 ng/mL (50-75 nmol/L) | Adequate (IOM) | Meets Institute of Medicine threshold; many pulmonologists target >30 ng/mL for asthma patients |
| 30-60 ng/mL (75-150 nmol/L) | Optimal | Target range for most adults; associated with best respiratory outcomes in observational data |
| >100 ng/mL (>250 nmol/L) | Potentially Toxic | Risk of hypercalcemia; avoid this range; requires dose adjustment |
Retest 3 months after starting supplementation to confirm your level has reached target. Annual testing is reasonable for asthma patients on maintenance supplementation.
| Food Source | Serving Size | Approximate Vitamin D (IU) | Notes |
|---|---|---|---|
| Salmon (wild-caught, cooked) | 3 oz (85g) | 570-700 IU | Best natural food source |
| Swordfish (cooked) | 3 oz | ~570 IU | Mercury concern with frequent intake |
| Canned tuna (light, in water) | 3 oz | ~150 IU | Convenient, affordable |
| Sardines (canned in oil) | 2 sardines | ~45 IU | Also rich in omega-3 fatty acids |
| Egg yolk | 1 large | ~40 IU | Higher in pasture-raised eggs |
| Fortified cow's milk | 1 cup (240 mL) | ~120 IU | Most milk in US is fortified |
| Fortified orange juice | 1 cup | ~100 IU | Check label; varies by brand |
| UV-exposed mushrooms | 1/2 cup | ~46-400+ IU | Portobello gills-up in sunlight 30 min increases D2 content significantly |
| Cod liver oil | 1 tablespoon | ~1,360 IU | High dose; also contains preformed vitamin A -- watch total intake |
Patients with severe asthma who take systemic corticosteroids long-term face compounded vitamin D depletion. Corticosteroids impair 25-OH D conversion to active calcitriol, increase renal calcium excretion, and reduce intestinal calcium absorption. If you are on maintenance oral prednisolone or frequent OCS bursts, vitamin D and calcium supplementation should be part of bone health management -- discuss this with your physician at your next visit. Long-term OCS use also increases risk for osteoporosis, and adequate vitamin D is one component of fracture prevention.
Patients prescribed biologics (mepolizumab, benralizumab, dupilumab, tezepelumab) for severe eosinophilic asthma should still address vitamin D deficiency. Biologics target specific inflammatory pathways; vitamin D provides broader immune modulation including antimicrobial defense against viral exacerbation triggers that biologics do not address. The two interventions are complementary, not mutually exclusive.
Pediatric asthma and vitamin D deficiency frequently co-occur. A prospective cohort study of 560 Puerto Rican children found that each 10 ng/mL increase in serum 25-OH D was associated with 35% lower odds of asthma hospitalization. For children, dosing is weight-based; the American Academy of Pediatrics recommends at least 400 IU/day for infants and 600 IU/day for children, with higher doses for confirmed deficiency under physician guidance. Always consult a pediatric pulmonologist or pediatrician before supplementing children.
Obesity is an independent asthma risk factor and a primary driver of vitamin D sequestration. Adipose tissue stores vitamin D but does not release it efficiently, reducing circulating 25-OH D even when dietary or supplemental intake is adequate. Obese patients typically require 2-3x higher supplementation doses to achieve the same serum level as normal-weight individuals. Weight loss tends to improve both asthma control and vitamin D status simultaneously -- and is a key management target in our obesity-related asthma protocol.
It is important to be clear about what the evidence supports and what it does not:
If your asthma remains poorly controlled despite optimized standard therapy -- including addressing vitamin D deficiency -- you may be a candidate for clinical research. The Lung Research Florida team at our affiliated research site conducts trials in severe asthma, COPD, and chronic cough. Active studies in the Plantation, FL area include investigational biologics and novel anti-inflammatory agents targeting mechanisms beyond the current approved drug classes.
Participation in a clinical trial is always voluntary, at no cost to participants, and all studies are conducted under IRB oversight with informed consent. Call 954-520-7296 x1 to ask about current eligibility criteria.
A simple blood test can determine whether vitamin D deficiency is contributing to your asthma attacks. Dr. Frank Hull's team at the Advanced Asthma Clinic in Plantation, FL evaluates all aspects of asthma control -- including nutritional factors, phenotyping, and eligibility for advanced therapies including biologics and clinical trials.
Schedule an AppointmentCall us: 954-522-7226 | Plantation, FL 33324
Yes. Multiple randomized controlled trials and meta-analyses show that vitamin D deficiency is associated with more frequent asthma attacks requiring oral corticosteroids, more emergency visits, and greater symptom burden. Correcting deficiency in confirmed low-level patients reduces exacerbation rate by approximately 30% based on the best available evidence. Consult your physician before supplementing.
Indoor air-conditioned lifestyle, consistent high-SPF sunscreen use, darker skin pigmentation, obesity, older age, malabsorption conditions, and chronic oral corticosteroid use can all prevent adequate vitamin D synthesis or storage even in high-UV climates. Many asthma patients also avoid outdoor heat and pollen -- which further reduces sun exposure opportunities.
Most pulmonologists target a serum 25-OH vitamin D level above 30 ng/mL (75 nmol/L) for asthma patients. The Institute of Medicine considers 20 ng/mL sufficient for the general population, but respiratory-focused clinicians often favor the higher threshold. Levels above 60-100 ng/mL are not necessary and carry increased toxicity risk. Always test before supplementing and retest after 3 months.
Vitamin D3 (cholecalciferol) is preferred. It is the naturally synthesized form and raises serum 25-OH D levels approximately 87% more effectively than D2 (ergocalciferol) at the same dose. Take it with a fat-containing meal to maximize absorption.
No. Vitamin D is not a cure for asthma. It is a complementary intervention that, when used to correct confirmed deficiency, can meaningfully reduce attack frequency. Your prescribed asthma medications -- inhaled corticosteroids, bronchodilators, and biologics if indicated -- remain the foundation of asthma management. Always consult your physician before changing your medication regimen.
Yes. Vitamin D toxicity (hypervitaminosis D) is real and causes hypercalcemia, which can lead to nausea, vomiting, weakness, frequent urination, kidney stones, and in severe cases cardiac arrhythmias. Toxicity typically occurs at sustained serum levels above 150 ng/mL, usually from high-dose supplementation (above 10,000 IU/day long-term) rather than from sun exposure or diet. Never take mega-doses without physician monitoring.
Medical Disclaimer: This content is provided for educational purposes by the Advanced Asthma Clinic, Plantation, FL, and is reviewed for accuracy by Dr. Frank Hull, Board-certified Pulmonologist. It does not constitute medical advice, diagnosis, or treatment recommendations. Individual health decisions should always be made in consultation with a qualified physician. Vitamin D supplementation should be guided by blood testing and physician oversight. If you are experiencing a medical emergency or acute asthma attack, call 911 immediately.